Related Experiment Video
Updated: Jun 10, 2026

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Cardiorespiratory and Glycaemic Changes Following Prehospital Nebulised Salbutamol in Acute Asthma: A Mixed
Craig Mortimer1,2, Dimitra Nikoletou3, Ann Ooms2
1Research and Development Department, South East Coast Ambulance Service NHS Foundation Trust, Crawley, UK.
Purpose:
In 2010, the Global Strategy for Asthma Management and Prevention recommended reducing the reliance on treating acute asthma exacerbations with short-acting β2 agonists (SABAs) given potential adverse effects. However, more than a decade later, SABAs, particularly nebulised salbutamol, remain at the forefront of acute asthma care. This study examined the physiological effects of nebulised salbutamol in patients experiencing moderate to severe asthma exacerbations.
Methods:
A six month, prospective and retrospective observational study was undertaken involving prehospital asthma patients treated with nebulised salbutamol. Data were analysed using descriptive and inferential statistics, including paired comparisons and exploratory subgroup analyses, to identify relevant trends and variability.
Results:
Among 176 eligible patients, reductions were observed in heart rate (mean -3 beats/min) and respiratory rate (mean -5 breaths/min), with modest improvement in peripheral oxygen saturation (+2%). Capillary blood glucose (CBG) analysis was conducted on a small prospective subgroup (n=8). A mean increase of +0.375 mmol/L was observed. When one clinically atypical outlier was excluded (n=7), the increase reached statistical significance. Albeit interpretation is limited by the small sample size.
Conclusion:
Administration of ≥5mg nebulised salbutamol in acute asthma exacerbations was transiently associated with improved peripheral oxygen saturation and respiratory parameter changes during the prehospital treatment period. No clinically significant increase in heart rate was observed overall. A small rise in CBG was observed in a small prospectively monitored subgroup. However, the clinical significance of this finding remains uncertain. Larger, adequately powered prospective studies are required to confirm these findings. The present findings are insufficient to recommend changes to current glucose monitoring practices in non-diabetic patients.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Inhaled Medications
